Todd Lynch Joins BioAgilytix Labs As SVP And Chief Financial Officer

DURHAM, N.C.--(BUSINESS WIRE)--BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has welcomed Todd Lynch, CPA to its executive leadership team as SVP and Chief Financial Officer. With more than 23 years of experience in biotechnology, big pharma, clinical diagnostics, and contract research organizations ranging from pre-revenue to Fortune 500 companies, Mr. Lynch will play a key role in the development and execution of strategies to support BioAgilytix's rapid growth.

Suggested Articles

A who’s who of Big Pharmas, including Pfizer, Johnson & Johnson and Merck, have banded together to bolster the development of new antibiotics.

Bayer's finerenone beat placebo at slowing kidney disease and cut the risk of heart attacks and strokes in diabetic kidney disease patients.

The National Institute of Allergy and Infectious Diseases is launching a new clinical trials network for COVID-19.